vs
ARDELYX, INC.（ARDX）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
ARDELYX, INC.的季度营收约是REPUBLIC BANCORP INC的1.0倍（$94.5M vs $94.3M），REPUBLIC BANCORP INC净利率更高（24.2% vs -39.8%，领先64.0%），ARDELYX, INC.同比增速更快（27.5% vs 5.3%），过去两年ARDELYX, INC.的营收复合增速更高（13.6% vs -11.5%）
Ardelyx是一家商业化阶段的生物制药企业，专注于研发和商业化针对胃肠道、心肾及代谢类疾病的创新疗法，其核心产品已在美国获批用于治疗便秘型肠易激综合征，同时拥有涵盖多适应症的各阶段研发管线。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
ARDX vs RBCAA — 直观对比
营收规模更大
ARDX
是对方的1.0倍
$94.3M
营收增速更快
ARDX
高出22.2%
5.3%
净利率更高
RBCAA
高出64.0%
-39.8%
两年增速更快
ARDX
近两年复合增速
-11.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $94.5M | $94.3M |
| 净利润 | $-37.6M | $22.8M |
| 毛利率 | — | — |
| 营业利润率 | — | 29.3% |
| 净利率 | -39.8% | 24.2% |
| 营收同比 | 27.5% | 5.3% |
| 净利润同比 | — | 20.0% |
| 每股收益（稀释后） | $-0.15 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARDXRBCAA
| Q1 26 | $94.5M | — | ||
| Q4 25 | $125.2M | $94.3M | ||
| Q3 25 | $110.3M | $93.5M | ||
| Q2 25 | $97.7M | $93.8M | ||
| Q1 25 | $74.1M | $135.8M | ||
| Q4 24 | $116.1M | $89.5M | ||
| Q3 24 | $98.2M | $88.1M | ||
| Q2 24 | $73.2M | $86.9M |
净利润ARDXRBCAA
| Q1 26 | $-37.6M | — | ||
| Q4 25 | $-407.0K | $22.8M | ||
| Q3 25 | $-969.0K | $29.7M | ||
| Q2 25 | $-19.1M | $31.5M | ||
| Q1 25 | $-41.1M | $47.3M | ||
| Q4 24 | $4.6M | $19.0M | ||
| Q3 24 | $-809.0K | $26.5M | ||
| Q2 24 | $-16.5M | $25.2M |
毛利率ARDXRBCAA
| Q1 26 | — | — | ||
| Q4 25 | 91.3% | — | ||
| Q3 25 | 96.4% | — | ||
| Q2 25 | 87.3% | — | ||
| Q1 25 | 83.4% | — | ||
| Q4 24 | 84.3% | — | ||
| Q3 24 | 84.0% | — | ||
| Q2 24 | 87.1% | — |
营业利润率ARDXRBCAA
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | 29.3% | ||
| Q3 25 | 4.2% | 40.4% | ||
| Q2 25 | -14.7% | 43.0% | ||
| Q1 25 | -49.0% | 44.1% | ||
| Q4 24 | 7.0% | 25.8% | ||
| Q3 24 | 2.3% | 38.4% | ||
| Q2 24 | -18.6% | 37.0% |
净利率ARDXRBCAA
| Q1 26 | -39.8% | — | ||
| Q4 25 | -0.3% | 24.2% | ||
| Q3 25 | -0.9% | 31.8% | ||
| Q2 25 | -19.5% | 33.5% | ||
| Q1 25 | -55.5% | 34.8% | ||
| Q4 24 | 4.0% | 21.2% | ||
| Q3 24 | -0.8% | 30.1% | ||
| Q2 24 | -22.5% | 29.0% |
每股收益（稀释后）ARDXRBCAA
| Q1 26 | $-0.15 | — | ||
| Q4 25 | $-0.01 | — | ||
| Q3 25 | $0.00 | — | ||
| Q2 25 | $-0.08 | — | ||
| Q1 25 | $-0.17 | — | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $0.00 | — | ||
| Q2 24 | $-0.07 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $238.1M | $220.0M |
| 总债务越低越好 | $203.5M | — |
| 股东权益账面价值 | $148.6M | $1.1B |
| 总资产 | $504.5M | $7.0B |
| 负债/权益比越低杠杆越低 | 1.37× | — |
8季度趋势，按日历期对齐
现金及短期投资ARDXRBCAA
| Q1 26 | $238.1M | — | ||
| Q4 25 | $68.0M | $220.0M | ||
| Q3 25 | $42.7M | $484.2M | ||
| Q2 25 | $90.0M | $484.8M | ||
| Q1 25 | $30.8M | $793.0M | ||
| Q4 24 | $64.9M | $432.2M | ||
| Q3 24 | $47.4M | $530.9M | ||
| Q2 24 | $41.9M | $400.1M |
总债务ARDXRBCAA
| Q1 26 | $203.5M | — | ||
| Q4 25 | $202.8M | — | ||
| Q3 25 | $202.1M | — | ||
| Q2 25 | $201.4M | — | ||
| Q1 25 | $151.3M | — | ||
| Q4 24 | $150.9M | — | ||
| Q3 24 | $100.7M | — | ||
| Q2 24 | $100.2M | — |
股东权益ARDXRBCAA
| Q1 26 | $148.6M | — | ||
| Q4 25 | $166.9M | $1.1B | ||
| Q3 25 | $154.3M | $1.1B | ||
| Q2 25 | $139.5M | $1.1B | ||
| Q1 25 | $145.7M | $1.0B | ||
| Q4 24 | $173.3M | $992.0M | ||
| Q3 24 | $158.3M | $979.7M | ||
| Q2 24 | $147.0M | $955.4M |
总资产ARDXRBCAA
| Q1 26 | $504.5M | — | ||
| Q4 25 | $501.6M | $7.0B | ||
| Q3 25 | $486.2M | $7.0B | ||
| Q2 25 | $466.8M | $7.0B | ||
| Q1 25 | $410.2M | $7.1B | ||
| Q4 24 | $435.8M | $6.8B | ||
| Q3 24 | $367.9M | $6.7B | ||
| Q2 24 | $343.5M | $6.6B |
负债/权益比ARDXRBCAA
| Q1 26 | 1.37× | — | ||
| Q4 25 | 1.21× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 1.44× | — | ||
| Q1 25 | 1.04× | — | ||
| Q4 24 | 0.87× | — | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.68× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $168.2M |
| 自由现金流经营现金流 - 资本支出 | — | $161.1M |
| 自由现金流率自由现金流/营收 | — | 170.9% |
| 资本支出强度资本支出/营收 | — | 7.5% |
| 现金转化率经营现金流/净利润 | — | 7.37× |
| 过去12个月自由现金流最近4个季度 | — | $288.6M |
8季度趋势，按日历期对齐
经营现金流ARDXRBCAA
| Q1 26 | — | — | ||
| Q4 25 | $21.0M | $168.2M | ||
| Q3 25 | $365.0K | $33.3M | ||
| Q2 25 | $-25.3M | $8.4M | ||
| Q1 25 | $-38.5M | $93.2M | ||
| Q4 24 | $9.8M | $149.0M | ||
| Q3 24 | $501.0K | $51.3M | ||
| Q2 24 | $-19.4M | $4.0M |
自由现金流ARDXRBCAA
| Q1 26 | — | — | ||
| Q4 25 | $20.6M | $161.1M | ||
| Q3 25 | $209.0K | $30.8M | ||
| Q2 25 | $-26.0M | $5.2M | ||
| Q1 25 | $-38.8M | $91.6M | ||
| Q4 24 | $9.2M | $143.2M | ||
| Q3 24 | $364.0K | $49.8M | ||
| Q2 24 | $-19.5M | $2.7M |
自由现金流率ARDXRBCAA
| Q1 26 | — | — | ||
| Q4 25 | 16.4% | 170.9% | ||
| Q3 25 | 0.2% | 32.9% | ||
| Q2 25 | -26.6% | 5.5% | ||
| Q1 25 | -52.3% | 67.4% | ||
| Q4 24 | 7.9% | 160.0% | ||
| Q3 24 | 0.4% | 56.5% | ||
| Q2 24 | -26.7% | 3.1% |
资本支出强度ARDXRBCAA
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 7.5% | ||
| Q3 25 | 0.1% | 2.6% | ||
| Q2 25 | 0.7% | 3.5% | ||
| Q1 25 | 0.4% | 1.2% | ||
| Q4 24 | 0.5% | 6.5% | ||
| Q3 24 | 0.1% | 1.7% | ||
| Q2 24 | 0.2% | 1.5% |
现金转化率ARDXRBCAA
| Q1 26 | — | — | ||
| Q4 25 | — | 7.37× | ||
| Q3 25 | — | 1.12× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | 2.11× | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARDX
| IBSRELA | $70.1M | 74% |
| XPHOZAH | $23.3M | 25% |
| Non-cash royalty revenue related to the sale of future royalties | $695.0K | 1% |
| Product supply revenue | $354.0K | 0% |
RBCAA
暂无分部数据
